Drugs Information:
Saxagliptin
Basic Information
|
|
||
| ID | DDInter1646 | |
| Drug Type | small molecule | |
| Molecular Formula | C18H25N3O2 | |
| Molecular Weight | 315.410 | |
| CAS Number | 361442-04-8 | |
| Description | Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009. | |
| ATC Classification | A10BD21 A10BD25 A10BH03 A10BD10 | |
| IUPAC Name | (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | |
| InChI | QGJUIPDUBHWZPV-SGTAVMJGSA-N | |
| Canonical SMILES | [H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2 | |
| Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Wikipedia ChEMBL | |
Interactions with
Saxagliptin
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|